GOH YVONNE

PrivateCIK: 2127830

GOH YVONNE enters CYTOMED THERAPEUTICS LTD with 25.78K shares — 100% direct ownership

Full direct ownership at entry is the strongest form of insider alignment with shareholders.

Direct
InsiderGOH YVONNECIK 2127830
IssuerCYTOMED THERAPEUTICS LTDCIK 1873093
Officer· Chief Financial Officer
Since Mar 2026
25.78K
Baseline shares
100% direct
25.78K
Direct ownership
1 position
0.00
Derivative underlying
0 instruments
1
Security positions
All direct
Non-Derivative Holdings1

Ordinary Shares, no par value per share

Direct
Shares owned25.78K
Total
25.78K direct25.78K
Derivative Holdings0
No derivative holdings reported
GOH YVONNE — Initial Ownership Disclosure (Form 3) Filed May 15, 2026 | Finecho